|
Kirby, L G; Pernar, L; Valentino, R J et al. (2003) Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 116:669-83
|
|
Neumaier, J F; Sexton, T J; Hamblin, M W et al. (2000) Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Res Mol Brain Res 82:65-73
|
|
Bacon, W L; Beck, S G (2000) 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 294:672-9
|
|
Muma, N A; Beck, S G (1999) Corticosteroids alter G protein inwardly rectifying potassium channels protein levels in hippocampal subfields. Brain Res 839:331-5
|
|
Okuhara, D Y; Beck, S G (1998) Corticosteroids influence the action potential firing pattern of hippocampal subfield CA3 pyramidal cells. Neuroendocrinology 67:58-66
|
|
Okuhara, D Y; Beck, S G (1998) Corticosteroids alter 5-hydroxytryptamine1A receptor-effector pathway in hippocampal subfield CA3 pyramidal cells. J Pharmacol Exp Ther 284:1227-33
|
|
Okuhara, D Y; Beck, S G; Muma, N A (1997) Corticosterone alters G protein alpha-subunit levels in the rat hippocampus. Brain Res 745:144-51
|
|
Birnstiel, S; Wulfert, E; Beck, S G (1997) Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 356:611-8
|
|
Beck, S G; Birnstiel, S; Choi, K C et al. (1997) Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J Pharmacol Exp Ther 281:115-22
|
|
Okuhara, D Y; Lee, J M; Beck, S G et al. (1996) Differential immunohistochemical labeling of Gs, G(il) and 2, and G(o) alpha-subunits in rat forebrain. Synapse 23:246-57
|
Showing the most recent 10 out of 21 publications
